Key Action Statement Profile: KAS 2
| Aggregate evidence quality | Grade B |
| Benefits | Relieves the major symptom of AOM. |
| Risks, harms, cost | Potential medication adverse effects. Variable efficacy of some modes of treatment. |
| Benefits-harms assessment | Preponderance of benefit. |
| Value judgments | Treating pain is essential whether or not antibiotics are prescribed. |
| Intentional vagueness | Choice of analgesic is not specified. |
| Role of patient preferences | Parents may assist in the decision as to what means of pain relief they prefer. |
| Exclusions | Topical analgesics in the presence of a perforated TM. |
| Strength | Strong Recommendation |
| Aggregate evidence quality | Grade B |
| Benefits | Relieves the major symptom of AOM. |
| Risks, harms, cost | Potential medication adverse effects. Variable efficacy of some modes of treatment. |
| Benefits-harms assessment | Preponderance of benefit. |
| Value judgments | Treating pain is essential whether or not antibiotics are prescribed. |
| Intentional vagueness | Choice of analgesic is not specified. |
| Role of patient preferences | Parents may assist in the decision as to what means of pain relief they prefer. |
| Exclusions | Topical analgesics in the presence of a perforated TM. |
| Strength | Strong Recommendation |